M&A Deal Summary

Emergent BioSolutions Acquires Protein Sciences

On January 6, 2009, Emergent BioSolutions acquired life science company Protein Sciences from Ropart Asset Management

Acquisition Highlights
  • This is Emergent BioSolutions’ 2nd transaction in the Life Science sector.
  • This is Emergent BioSolutions’ 2nd transaction in the United States.
  • This is Emergent BioSolutions’ 1st transaction in Connecticut.

M&A Deal Summary
Date 2009-01-06
Target Protein Sciences
Sector Life Science
Buyer(s) Emergent BioSolutions
Sellers(s) Ropart Asset Management
Deal Type Add-on Acquisition

Target

Protein Sciences

Meriden, Connecticut, United States
Protein Sciences Corporation (PSC) is a vaccine company that is dedicated to the development and commercialization of vaccines and biopharmaceuticals. PSC uses its patented baculovirus expression vector system (BEVS) manufacturing technology to make the next generation of safer and more effective human and veterinary vaccines, therapeutics and diagnostics. In addition, PSC provides product development and contract manufacturing services, as well as research products for the scientific community.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Emergent BioSolutions

Gaithersburg, Maryland, United States
Category Company
Founded 1998
Sector Healthcare Services
Employees1,600
Revenue 1.0B USD (2023)
DESCRIPTION

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergent BioSolutions was founded in 1998 and is based in Gaithersburg, Maryland.

DEAL STATS #
Overall 2 of 11
Sector (Life Science) 2 of 7
Type (Add-on Acquisition) 1 of 5
State (Connecticut) 1 of 1
Country (United States) 2 of 7
Year (2009) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-06 Avanir - Monoclonal Anthrax Product

United States

AVP-21D9 is a human monoclonal antibody product candidate that is being developed as an intravenous treatment for patients who present with symptoms of anthrax disease following exposure to Bacillus anthracis. In non-clinical studies, this candidate demonstrated an ability to protect animals challenged with a lethal dose of inhaled anthrax spores.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-13 MdBio Foundation - Foot Manufacturing Facility

United States

MdBio Foundation - Foot Manufacturing Facility operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.

Buy $8M

Seller(S) 1

SELLER

Ropart Asset Management

Greenwich, Connecticut, United States

Investor

Category Private Equity Firm
Founded 2001
Size Small
Type Sector Agnostic
DESCRIPTION

Ropart Asset Management (RAM) is a private equity firm that provides both debt and equity capital to small and middle market companies. RAM segments its investment activity between platform investments, mezzanine situations, and growth capital financings. For platform investments, RAM requires control and targets generally targets businesses with recurring revenue ($10 to $150 million) and clear opportunities for value-added change. The Firm generally looks to invest $3 to $15 million in businesses valued up to $100 million. Areas of interest include business services, industrial services, direct marketing, software/technology, consumer products, value-added distributions, infrastructure/logistics, human capital, hobbies/crafts, franchisors, financial services and healthcare services. Ropart Asset Management was founded in 2001 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 7 of 16
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 6 of 15
State (Connecticut) 1 of 1
Country (United States) 7 of 16
Year (2009) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-05 Advanced Practice Systems

Effingham, Illinois, United States

Advanced Practice Systems (known in the marketplace as PTOS Software is the leader in the physical therapy practice management software industry. APS provides computerized billing and office management software to over 3,500 therapy practices and rehabilitation agencies across the U.S. In addition to billing, the company’s software facilitates management report production, scheduling, documentation, accounting, and customer support.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-05-25 Lane Berry International

Boston, Massachusetts, United States

Lane Berry is an investment bank that provides strategic advisory and capital markets advisory services to growth companies. Strategic advisory services assist clients with mergers & acquisitions, strategic alternatives, restructurings, and corporate governance opportunities, while capital markets advisory services assist clients with private and public debt/equity financing, recapitalizations, and share repurchases.

Sell -
Mergr

Product

Company

Legal